It'll be interesting to see what the brokers make of the development. However, we'll have to work out who was adviser to the deal and who was unhappy thye weren't.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025